SKIN

The Beauty Health Company Class A Common Stock

1.27

USD

SKIN Earnings Reports

Positive Surprise Ratio

SKIN beat 14 of 19 last estimates.

74%

Next Report

Date of Next Report

Mar 10, 2026

Estimate for Q4 25 (Revenue/ EPS)

$79.31M

-$0.05

Implied change from Q3 25 (Revenue/ EPS)

+12.25%

-44.44%

Implied change from Q4 24 (Revenue/ EPS)

-5.01%

-37.50%

The Beauty Health Company Class A Common Stock earnings per share and revenue

On Nov 06, 2025, SKIN reported earnings of -0.09 USD per share (EPS) for Q3 25, missing the estimate of -0.06 USD, resulting in a -30.25% surprise. Revenue reached 70.66 million, compared to an expected 69.96 million, with a 0.99% difference. The market reacted with a +8.53% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 10 analysts forecast an EPS of -0.05 USD, with revenue projected to reach 79.31 million USD, implying an decrease of -44.44% EPS, and increase of 12.25% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

InnovAge Holding Corp. Common Stock

Report Date

Feb 03, 2026 For Q2 26

Estimate

$0.04

Actual

$0.08

Surprise

+96.08%

Embecta Corp. Common Stock

Report Date

Feb 05, 2026 For Q1 26

Estimate

$0.68

Actual

$0.71

Surprise

+3.89%

Danaher Corporation

Report Date

Jan 28, 2026 For Q4 25

Estimate

$2.17

Actual

$2.23

Surprise

+2.56%

HCA Healthcare, Inc.

Report Date

Jan 27, 2026 For Q4 25

Estimate

$7.53

Actual

$8.14

Surprise

+8.05%

Elevance Health, Inc.

Report Date

Jan 28, 2026 For Q4 25

Estimate

$3.12

Actual

$3.33

Surprise

+6.46%

Cencora, Inc.

Report Date

Feb 04, 2026 For Q1 26

Estimate

$4.07

Actual

$4.08

Surprise

+0.16%

Revvity, Inc.

Report Date

Feb 02, 2026 For Q4 25

Estimate

$1.58

Actual

$1.70

Surprise

+7.45%

FAQ

What were The Beauty Health Company Class A Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, The Beauty Health Company Class A Common Stock reported EPS of -$0.09, missing estimates by -30.25%, and revenue of $70.66M, 0.99% above expectations.

How did the market react to The Beauty Health Company Class A Common Stock's Q3 2025 earnings?

The stock price moved up 8.53%, changed from $1.29 before the earnings release to $1.40 the day after.

When is The Beauty Health Company Class A Common Stock expected to report next?

The next earning report is scheduled for Mar 10, 2026.

What are the forecasts for The Beauty Health Company Class A Common Stock's next earnings report?

Based on 10 analysts, The Beauty Health Company Class A Common Stock is expected to report EPS of -$0.05 and revenue of $79.31M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.